Sexual well-being and diurnal cortisol after prostate cancer treatment

Bibliographic Data

ID4227002
AuthorsMichael A Hoyt (0000-0003-2274-1902, Hunter College, City University of New York, USA), Allison E Gaffey (0000-0002-2960-2772, Rush University Medical Center), Ashley W Wang (Hunter College, City University of New York, USA), Ashley Wang (0000-0001-9740-2345), Mark S Litwin (0000-0002-2318-344X, University of California, Los Angeles), Catalina J Lawsin (Rush University Medical Center)
Year2020
Volume25
Issue10-11
Pages1796-1801
Publication date2020-09-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueJournal of Health Psychology (JOURNAL)
Journal identifiersISSN: 1359-1053 • E-ISSN: 1461-7277
PublisherSAGE Publications Inc (PUBLISHER)
DOI10.1177/1359105318772655
PMID29696999
OpenAlexW2802247243
LanguageEN
References cited28

Sexual dysfunction and psychological distress are common after prostate cancer. Research has not examined the role of neuroendocrine markers of stress (e.g. cortisol). This study examines whether sexual functioning or sexual bother is associated with diurnal cortisol. Men treated for prostate cancer completed the University of California-Los Angeles Prostate Cancer Index and provided saliva samples four times daily for cortisol assessment. Higher sexual bother, but not sexual functioning, was associated with steeper cortisol slope. Better sexual functioning, and not sexual bother, was significantly associated with the cortisol awakening response. Assessment of stress and stress-reducing interventions might be warranted in sexual rehabilitation after prostate cancer

Cancer · Distress · Prostate · Prostate cancer · Saliva · Sexual dysfunction · Cancer survivorship and care · Cancer, Stress, Anesthesia, and Immune Response · Medicine · Psychology · Stress Responses and Cortisol · Clinical Psychology · Internal Medicine · Oncology